Shares of DaVita HealthCare Partners Inc. (NYSE:DVA) have earned a consensus rating of “Hold” from the twelve brokerages that are currently covering the firm, MarketBeat Ratings reports. Two research analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have assigned a buy rating to the company. The average 1 year target price among analysts that have updated their coverage on the stock in the last year is $67.88.

DVA has been the subject of a number of recent research reports. BidaskClub downgraded DaVita HealthCare Partners from a “hold” rating to a “sell” rating in a research report on Saturday, July 8th. TheStreet downgraded DaVita HealthCare Partners from a “b” rating to a “c+” rating in a research report on Wednesday, August 2nd. Goldman Sachs Group, Inc. (The) restated a “sell” rating and set a $62.00 target price on shares of DaVita HealthCare Partners in a research report on Thursday, May 25th. Jefferies Group LLC set a $70.00 target price on DaVita HealthCare Partners and gave the stock a “buy” rating in a research report on Friday, May 26th. Finally, Zacks Investment Research upgraded DaVita HealthCare Partners from a “sell” rating to a “hold” rating in a research report on Thursday, August 3rd.

Several hedge funds and other institutional investors have recently bought and sold shares of DVA. SRS Capital Advisors Inc. boosted its position in DaVita HealthCare Partners by 6.6% in the first quarter. SRS Capital Advisors Inc. now owns 1,966 shares of the company’s stock valued at $133,000 after buying an additional 122 shares in the last quarter. Advisor Partners LLC purchased a new position in DaVita HealthCare Partners during the first quarter valued at $218,000. Wetherby Asset Management Inc. boosted its position in DaVita HealthCare Partners by 3.3% in the first quarter. Wetherby Asset Management Inc. now owns 3,224 shares of the company’s stock valued at $219,000 after buying an additional 104 shares in the last quarter. Pzena Investment Management LLC boosted its position in DaVita HealthCare Partners by 2.1% in the second quarter. Pzena Investment Management LLC now owns 3,398 shares of the company’s stock valued at $220,000 after buying an additional 71 shares in the last quarter. Finally, Pacer Advisors Inc. boosted its position in DaVita HealthCare Partners by 3.0% in the first quarter. Pacer Advisors Inc. now owns 3,422 shares of the company’s stock valued at $233,000 after buying an additional 101 shares in the last quarter. 83.43% of the stock is owned by institutional investors.

WARNING: This report was originally posted by American Banking News and is the sole property of of American Banking News. If you are accessing this report on another site, it was illegally copied and reposted in violation of US and international trademark and copyright law. The correct version of this report can be viewed at https://www.americanbankingnews.com/2017/08/30/davita-healthcare-partners-inc-dva-receives-consensus-recommendation-of-hold-from-analysts.html.

Shares of DaVita HealthCare Partners (DVA) traded up 0.79% during midday trading on Wednesday, hitting $57.52. 1,069,909 shares of the company’s stock traded hands. DaVita HealthCare Partners has a 52 week low of $54.50 and a 52 week high of $70.16. The stock has a market cap of $11.00 billion, a P/E ratio of 8.76 and a beta of 0.89. The company has a 50 day moving average of $60.86 and a 200 day moving average of $65.12.

DaVita HealthCare Partners (NYSE:DVA) last issued its quarterly earnings data on Tuesday, August 1st. The company reported $0.92 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.90 by $0.02. DaVita HealthCare Partners had a return on equity of 14.02% and a net margin of 8.68%. The firm had revenue of $3.88 billion during the quarter, compared to the consensus estimate of $3.82 billion. During the same quarter in the previous year, the company posted $1.01 EPS. The business’s revenue for the quarter was up 4.3% compared to the same quarter last year. On average, equities analysts forecast that DaVita HealthCare Partners will post $3.59 EPS for the current fiscal year.

DaVita HealthCare Partners Company Profile

DaVita Inc, formerly DaVita HealthCare Partners Inc, operates two divisions: DaVita Kidney Care (Kidney Care) and DaVita Medical Group (DMG). The Kidney Care division consists of its the United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations, and its corporate administrative support.

Analyst Recommendations for DaVita HealthCare Partners (NYSE:DVA)

Receive News & Ratings for DaVita HealthCare Partners Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DaVita HealthCare Partners Inc. and related companies with MarketBeat.com's FREE daily email newsletter.